Title: Strategies to Overcome Biological Barriers to Biosensing
Abstract: Chapter 3 Strategies to Overcome Biological Barriers to Biosensing W. Kenneth Ward, W. Kenneth Ward Divsion of Endocrinology, Diabetes and Clinical Nutrition, Oregon Health & Sciences University, Portland, OR, USASearch for more papers by this authorHeather M. Duman, Heather M. Duman Legacy Clinical Research and Technology Center, Portland, OR, USASearch for more papers by this author W. Kenneth Ward, W. Kenneth Ward Divsion of Endocrinology, Diabetes and Clinical Nutrition, Oregon Health & Sciences University, Portland, OR, USASearch for more papers by this authorHeather M. Duman, Heather M. Duman Legacy Clinical Research and Technology Center, Portland, OR, USASearch for more papers by this author Book Editor(s):David D. Cunningham, David D. Cunningham Abbott Laboratories, Abbott Park, IL, USASearch for more papers by this authorJulie A. Stenken, Julie A. Stenken Department of Chemistry and Biochemistry, University of Arkansas, Fayetteville, AR, USASearch for more papers by this author First published: 23 November 2009 https://doi.org/10.1002/9780470567319.ch3Citations: 1 Series Editor(s): J. D. Winefordner, J. D. WinefordnerSearch for more papers by this author AboutPDFPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShareShare a linkShare onEmailFacebookTwitterLinkedInRedditWechat Summary This chapter contains sections titled: Introduction The Early Foreign Body Reaction (Minutes to Days) Subacute and Chronic Effects (Days to Months) Surface Microgeometry Surface Chemistry Device Motion Methods to Reduce the Foreign Body Reaction Summary Acknowledgments References REFERENCES Tang L, Eaton JW. Fibrin(ogen) mediates acute inflammatory responses to biomaterials. Journal of Experimental Medicine 1993, 178, 2147–2156. 10.1084/jem.178.6.2147 CASPubMedWeb of Science®Google Scholar Tang L, Ugarova TP, Plow EF, Eaton JW. Molecular determinants of acute inflammatory responses to biomaterials. Journal of Clinical Investigation 1996, 97, 1329–1334. 10.1172/JCI118549 CASPubMedWeb of Science®Google Scholar Tang L, Wu Y, Timmons RB. Fibrinogen adsorption and host tissue responses to plasma functionalized surfaces. Journal of Biomedical Materials Research 1998, 42, 156–163. 10.1002/(SICI)1097-4636(199810)42:1<156::AID-JBM19>3.0.CO;2-J CASPubMedWeb of Science®Google Scholar Ward WK, Wood MD, Casey HM, Quinn MJ, Federiuk IF. An implantable subcutaneous glucose sensor array in ketosis-prone rats: closed loop glycemic control. Artificial Organs 2005, 29, 131–143. 10.1111/j.1525-1594.2005.29024.x CASPubMedWeb of Science®Google Scholar Zdolsek J, Eaton JW, Tang L. Histamine release and fibrinogen adsorption mediate acute inflammatory responses to biomaterial implants in humans. Journal of Translational Medicine 2007, 5, 31. 10.1186/1479-5876-5-31 CASPubMedWeb of Science®Google Scholar Tang L, Jennings TA, Eaton JW. Mast cells mediate acute inflammatory responses to implanted biomaterials. Proceedings of the National Academy of Sciences of the United States of America 1998, 95, 8841–8846. 10.1073/pnas.95.15.8841 CASPubMedWeb of Science®Google Scholar Greenhalgh D. The role of monocytes/macrophages in wound healing. In: Robinson JP, Babcock GF (Eds), Phagocyte Function: A Guide for Research and Clinical Evaluation. Wiley-Liss Inc., 1998, pp. 349–357. Google Scholar Kao WJ, McNally AK, Hiltner A, Anderson JM. Role for interleukin-4 in foreign-body giant cell formation on a poly(etherurethane urea) in vivo . Journal of Biomedical Materials Research 1995, 29, 1267–1275. 10.1002/jbm.820291014 CASPubMedWeb of Science®Google Scholar Tsai AT, Rice J, Scatena M, Liaw L, Ratner BD, Giachelli CM. The role of osteopontin in foreign body giant cell formation. Biomaterials 2005, 26, 5835–5843. 10.1016/j.biomaterials.2005.03.003 CASPubMedWeb of Science®Google Scholar El-Warrak AO, Olmstead M, Apelt D, Deiss F, Noetzli H, Zlinsky K, Hilbe M, Bertschar-Wolfsberger R, Johnson AL, Auer J, von Rechenberg B. An animal model for interface tissue formation in cemented hip replacements. Veterinary Surgery 2004, 33, 495–504. 10.1111/j.1532-950X.2004.04064.x PubMedWeb of Science®Google Scholar Wozniak W, Markuszewski J, Wierusz-Kozlowska M, Wysocki H. Neutrophils are active in total joint implant loosening. Acta Orthopaedica Scandinavica 2004, 75, 549–553. 10.1080/00016470410001402 PubMedWeb of Science®Google Scholar Sharkawy AA, Klitzman B, Truskey GA, Reichert WM. Engineering the tissue which encapsulates subcutaneous implants. I. Diffusion properties. Journal of Biomedical Materials Research 1997, 37, 401–412. 10.1002/(SICI)1097-4636(19971205)37:3<401::AID-JBM11>3.0.CO;2-E CASPubMedWeb of Science®Google Scholar Sharkawy AA, Klitzman B, Truskey GA, Reichert WM. Engineering the tissue which encapsulates subcutaneous implants. II. Plasma–tissue exchange properties. Journal of Biomedical Materials Research 1998, 40, 586–597. 10.1002/(SICI)1097-4636(19980615)40:4<586::AID-JBM10>3.0.CO;2-E CASPubMedWeb of Science®Google Scholar Wisniewski N, Moussy F, Reichert WM. Characterization of implantable biosensor membrane biofouling. Fresenius Journal of Analytical Chemistry 2000, 366, 611–621. 10.1007/s002160051556 CASPubMedWeb of Science®Google Scholar Wisniewski N, Reichert M. Methods for reducing biosensor membrane biofouling. Colloids and Surfaces B. Biointerfaces 2000, 18, 197–219. 10.1016/S0927-7765(99)00148-4 CASPubMedWeb of Science®Google Scholar Li AG, Quinn MJ, Siddiqui Y, Wood MD, Federiuk IF, Duman HM, Ward WK. Elevation of transforming growth factor beta (TGFbeta) and its downstream mediators in subcutaneous foreign body capsule tissue. Journalof Biomedical Materials Research A 82, 2007, 498–508. 10.1002/jbm.a.31168 CASPubMedWeb of Science®Google Scholar Ward WK, Li AG, Siddiqui Y, Federiuk IF, Wang X-J. Increased expression of interleukin-13 and connective tissue growth factor, and their potential roles during foreign body encapsulation of subcutaneous implants. Journal of Biomaterials Science, Polymer Edition 2008, 19, 1065–1072. 10.1163/156856208784909408 CASPubMedWeb of Science®Google Scholar Border WA. Transforming growth factor-βhe pathogenesis of glomerular diseases. Current Opinion in Nephrology and Hypertension 1994, 3, 54–58. 10.1097/00041552-199401000-00007 PubMedGoogle Scholar Chen K, Wei Y, Sharp GC, Braley-Mullen H. Inhibition of TGFβnti-TGFβbody or lisinopril reduces thyroid fibrosis in granulomatous experimental autoimmune thyroiditis. Journal of Immunology 2002, 169, 6530–6538. 10.4049/jimmunol.169.11.6530 CASPubMedWeb of Science®Google Scholar Atamas SP, White B. The role of chemokines in the pathogenesis of scleroderma. Current Opinion in Rheumatology 2003, 15, 772–777. 10.1097/00002281-200311000-00015 CASPubMedWeb of Science®Google Scholar Leask A, Abraham DJ. TGF-βling and the fibrotic response. Journal of the Federation of American Societies for Experimental Biology 2004, 18, 816–827. 10.1096/fj.03-1273rev CASPubMedWeb of Science®Google Scholar Parekh T, Saxena B, Reibman J, Cronstein BN, Gold LI. Neutrophil chemotaxis in response to TGF-βms (TGF-b1, TGF-b2, TGF-b3) is mediated by fibronectin. Journal of Immunology 1994, 152, 2456–2466. CASPubMedWeb of Science®Google Scholar Brodbeck WG, Voskerician G, Ziats NP, Nakayama Y, Matsuda T, Anderson JM. In vivo leukocyte cytokine mRNA responses to biomaterials are dependent on surface chemistry. Journal of Biomedical Materials Research A 2003, 64, 320–329. 10.1002/jbm.a.10425 CASPubMedWeb of Science®Google Scholar Robitaille R, Dusseault J, Henley N, Desbiens K, Labrecque N, Halle J-P. Inflammatory response to peritoneal implantation of alginate-poly-L-lysine microcapsules. Biomaterials 2005, 26, 4119–4127. 10.1016/j.biomaterials.2004.10.028 CASPubMedWeb of Science®Google Scholar O'Kane S, Ferguson MW. Transforming growth factor-bs and wound healing. International Journal of Biochemistry and Cell Biology 1997, 29, 63–78. 10.1016/S1357-2725(96)00120-3 CASPubMedWeb of Science®Google Scholar McCormick LL, Zhang Y, Tootell E, Gilliam AC. Anti-TGF-b treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma. Journal of Immunology 1999, 163, 5693–5699. CASPubMedWeb of Science®Google Scholar Hetzel GR, Hermsen D, Hohlfeld T, Rettich A, Ozcan F, Fussholler A, Grabensee B, Plum J. Effects of candesartan and perindopril on renal function, TGF-b1 plasma levels and excretion of prostaglandins in stable renal allograft recipients. Clinical Nephrology 2002, 57, 296–302. 10.5414/CNP57296 CASPubMedWeb of Science®Google Scholar Oriente A, Fedarko NS, Pacocha SE, Huang S-K, Lichtenstein LM, Essayan DM. Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts. Journal of Pharmacology and Experimental Therapeutics 2000, 292, 988–994. CASPubMedWeb of Science®Google Scholar Jinnin M, Ihn H, Yamane K, Tamaki K. Interleukin-13 stimulates the transcription of the human a2(I) collagen gene in human dermal fibroblasts. Journal of Biological Chemistry 2004, 279, 41783–41791. 10.1074/jbc.M406951200 CASPubMedWeb of Science®Google Scholar Joshi BH, Hogaboam C, Dover P, Husain SR, Puri RK. Role of interleukin-13 in cancer, pulmonary fibrosis, and other T(H)2-type diseases. Vitamins and Hormones 2006, 74, 479–504. 10.1016/S0083-6729(06)74019-5 CASPubMedWeb of Science®Google Scholar Lee CG, Homer RJ, Zhu Z, Lanone S, Wang X, Koteliansky V, Shipley JM, Gotwals P, Noble P, Chen Q, Senior RM, Elias JA. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor-b1. Journal of Experimental Medicine 2001, 194, 809–821. 10.1084/jem.194.6.809 CASPubMedWeb of Science®Google Scholar Fichtner-Feigl S, Strober W, Kawakami K, Puri RK, Kitani A. IL-13 signaling through the IL-13a2 receptor is involved in induction of TGF-b1 production and fibrosis. Nature Medicine 2006, 12, 99–106. 10.1038/nm1332 CASPubMedWeb of Science®Google Scholar Kaviratne M, Hesse M, Leusink M, Cheever AW, Davies SJ, McKerrow JH, Wakefield LM, Letterio JJ, Wynn TA. IL-13 activates a mechanism of tissue fibrosis that is completely TGF-b independent. Journal of Immunology 2004, 173, 4020–4029. 10.4049/jimmunol.173.6.4020 CASPubMedWeb of Science®Google Scholar Chen MM, Lam A, Abraham JA, Schreiner GF, Joly AH. CTGF expression is induced by TGF-b in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. Journal of Molecular and Cellular Cardiology 2000, 32, 1805–1819. 10.1006/jmcc.2000.1215 CASPubMedWeb of Science®Google Scholar Yokoi H, Sugawara A, Mukoyama M, Mori K, Makino H, Suganami T, Nagae T, Yahata K, Fujinaga Y, Tanaka I, Nakao K. Role of connective tissue growth factor in profibrotic action of transforming growth factor-beta: a potential target for preventing renal fibrosis. American Journal of Kidney Diseases 2001, 38, S134–S138. 10.1053/ajkd.2001.27422 CASPubMedWeb of Science®Google Scholar Colwell AS, Phan TT, Kong W, Longaker MT, Lorenz PH. Hypertrophic scar fibroblasts have increased connective tissue growth factor expression after transforming growth factor-b stimulation. Plastic and Reconstructive Surgery 2005, 116, 1387–1390; discussion 1391–1392. 10.1097/01.prs.0000182343.99694.28 CASPubMedWeb of Science®Google Scholar Zhao Q, Chen N, Wang W-M, Lu J, Dai B-B. Effect of transforming growth factor-beta on activity of connective tissue growth factor gene promoter in mouse NIH/3T3 fibroblasts. Acta Pharmacologica Sinica 2004, 25, 485–489. CASPubMedWeb of Science®Google Scholar Li MO, Wan YY, Sanjabi S, Robertson A-K, Flavell L, RA Transforming growth factor-b regulation of immune responses. Annual Reviews of Immunology 2006, 24, 99–146. 10.1146/annurev.immunol.24.021605.090737 CASPubMedWeb of Science®Google Scholar Pringle GA, Dodd CM. Immunoelectron microscopic localization of the core protein of decorin near the d and e bands of tendon collagen fibrils by use of monoclonal antibodies. Journal of Histochemistry and Cytochemistry 1990, 38, 1405–1411. 10.1177/38.10.1698203 CASPubMedWeb of Science®Google Scholar Danielson KG, Baribault H, Holmes DF, Graham H, Kadler KE, Iozzo RV. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. Journal of Cell Biology 1997, 136, 729–743. 10.1083/jcb.136.3.729 CASPubMedWeb of Science®Google Scholar Weston BS, Wahab NA, Mason RM. CTGF mediates TGF-b-induced fibronectin matrix deposition by upregulating active a5b1 integrin in human mesangial cells. Journal of the American Society of Nephrology 2003, 14, 601–610. 10.1097/01.ASN.0000051600.53134.B9 CASPubMedWeb of Science®Google Scholar Yung S, Lee CY, Zhang Q, Lau SK, Tsang RC, Chan TM. Elevated glucose induction of thrombospondin-1 upregulates fibronectin synthesis in proximal renal tubular epithelial cells through TGF-beta1 dependent and TGF-beta1 independent pathways. Nephrology Dialysis Transplantation 2006, 21, 1504–1513. 10.1093/ndt/gfl017 CASPubMedWeb of Science®Google Scholar Shah M, Foreman DM, Ferguson MW. Control of scarring in adult wounds by neutralising antibody to transforming growth factor beta. Lancet 1992, 339, 213–214. 10.1016/0140-6736(92)90009-R CASPubMedWeb of Science®Google Scholar Shah M, Foreman DM, Ferguson MW. Neutralising antibody to TGF-b1,2 reduces cutaneous scarring in adult rodents. Journal of Cell Science 1994, 107, 1137–1157. CASPubMedWeb of Science®Google Scholar Mori Y, Ishida W, Bhattacharyya S, Li Y, Platanias LC, Varga J. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts. Arthritis and Rheumatism 2004, 50, 4008–4021. 10.1002/art.20658 CASPubMedWeb of Science®Google Scholar Kusaba A, Fischer 3rd CR, Matulewski TJ, Matsumoto T. Experimental study of the influence of porosity on development of neointima in Gore-Tex grafts: a method to increase long-term patency rate. American Surgeon 1981, 47, 347–354. CASPubMedWeb of Science®Google Scholar Watanabe T. Experimental study on the influence of porosity on the development of the neointima in E-PTFE grafts. Nippon Geka Gakkai Zasshi 1984, 85, 580–591. CASPubMedGoogle Scholar Andrade SP, Fan TP, Lewis GP. Quantitative in-vivo studies on angiogenesis in a rat sponge model. British Journal of Experimental Pathology 1987, 68, 755–766. CASPubMedWeb of Science®Google Scholar Brauker JH, Carr-Brendel VE, Martinson LA, Crudele J, Johnston WD, Johnson RC. Neovascularization of synthetic membranes directed by membrane microarchitecture. Journal of Biomedical Materials Research 1995, 29, 1517–1524. 10.1002/jbm.820291208 CASPubMedWeb of Science®Google Scholar Updike SJ, Shults MC, Gilligan BJ, Rhodes RK. A subcutaneous glucose sensor with improved longevity, dynamic range, and stability of calibration. Diabetes Care 2000, 23, 208–214. 10.2337/diacare.23.2.208 CASPubMedWeb of Science®Google Scholar Ward WK, Slobodzian EP, Tiekotter KL, Wood MD. The effect of microgeometry, implant thickness and polyurethane chemistry on the foreign body response to subcutaneous implants. Biomaterials 2002, 23, 4185–4192. 10.1016/S0142-9612(02)00160-6 CASPubMedWeb of Science®Google Scholar Ward WK, Quinn MJ, Wood MD, Tiekotter KL, Pidikiti S, Gallagher JA. Vascularizing the tissuesurroundingamodelbiosensor:howlocalizedistheeffectofasubcutaneousinfusionof vascularendothelialgrowthfactor(VEGF)? Biosensors&Bioelectronics 2003, 19, 155–163. 10.1016/S0956-5663(03)00180-5 CASPubMedWeb of Science®Google Scholar Ward WK, Wood MD, Casey HM, Quinn MJ, Federiuk IF. The effect of local subcutaneous delivery of vascular endothelial growth factor on the function of a chronically-implanted amperometric glucose sensor. Diabetes Technology & Therapeutics 2004, 6, 137–145. 10.1089/152091504773731320 CASPubMedGoogle Scholar Voskerician G, Gingras PH, Anderson JM. Macroporous condensed poly (tetrafluoroethylene). I. In vivo inflammatory response and healing characteristics. Journal of Biomedical Materials Research A 2006, 76, 234–242. 10.1002/jbm.a.30481 CASPubMedWeb of Science®Google Scholar Sanders JE, Stiles CE, Hayes CL. Tissue response to single-polymer fibers of varying diameters: evaluation of fibrous encapsulation and macrophage density. Journal of Biomedical Materials Research 2000, 52, 231–237. 10.1002/1097-4636(200010)52:1<231::AID-JBM29>3.0.CO;2-E CASPubMedWeb of Science®Google Scholar Gross KA, Ezerietis E. Juniper wood as a possible implant material. Journal of Biomedical Materials Research A 2003, 64, 672–683. 10.1002/jbm.a.10437 PubMedWeb of Science®Google Scholar Aho AJ, Rekola J, Matinlinna J, Gunn J, Tirri T, Viitaniemi P, Vallittu P. Natural composite of wood as replacement material for ostechondral bone defects. Journal of Biomedical Materials Research B 2007, 83, 64–71. 10.1002/jbm.b.30767 CASPubMedWeb of Science®Google Scholar Smith HR. Do silicone breast implants cause autoimmune rheumatic diseases? Journal of Biomaterials Science, Polymer Edition 1995, 7, 115–121. 10.1163/156856295X00634 CASPubMedWeb of Science®Google Scholar Godin MS, Waldman SR, Johnson Jr CM. The use of expanded polytetrafluoroethylene (Gore-Tex) in rhinoplasty. A 6-year experience. Archives of Otolaryngology Head and Neck Surgery 1995, 121, 1131–1136. 10.1001/archotol.1995.01890100043007 CASPubMedWeb of Science®Google Scholar Hurst BS. Permanent implantation of expanded polytetrafluoroethylene is safe for pelvic surgery. United States Expanded Polytetrafluoroethylene Reproductive Surgery Study Group. Human Reproduction 1999, 14, 925–927. 10.1093/humrep/14.4.925 CASPubMedWeb of Science®Google Scholar Midasch O, Drexler H, Hart N, Beckmann MW, Angerer J. Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study. International Archives of Occupational and Environmental Health 2007, 80, 643–648. 10.1007/s00420-006-0165-9 CASPubMedWeb of Science®Google Scholar Wolf CJ, Fenton SE, Schmid JE, Calafat AM, Kuklenyik Z, Bryant XA, Thibodeaux J, Das KP, White SS, Lau CS, Abbott BD. Developmental toxicity of perfluorooctanoic acid in the CD-1 mouse after cross-foster and restricted gestational exposures. Toxicological Sciences 2007, 95, 462–473. 10.1093/toxsci/kfl159 CASPubMedWeb of Science®Google Scholar http://www.epa.gov/opptintr/pfoa/pubs/pfoainfo.htm#concerns (accessed on August 19, 2007). Google Scholar Christenson EM, Anderson JM, Hiltner A. Antioxidant inhibition of poly(carbonate urethane) in vivo biodegradation. Journal of Biomedical Materials Research A 2006, 76, 480–490. 10.1002/jbm.a.30506 CASPubMedWeb of Science®Google Scholar Mathur AB, Collier TO, Kao WJ, Wiggins M, Schubert MA, Hiltner A, Anderson JM. In vivo biocompatibility and biostability of modified polyurethanes. Journal of Biomedical Materials Research 1997, 36, 246–257. 10.1002/(SICI)1097-4636(199708)36:2<246::AID-JBM14>3.0.CO;2-E CASPubMedWeb of Science®Google Scholar Wiggins MJ, MacEwan M, Anderson JM, Hiltner A. Effect of soft-segment chemistry on polyurethane biostability during in vitro fatigue loading. Journal of Biomedical Materials Research A 2004, 68, 668–683. 10.1002/jbm.a.20081 CASPubMedWeb of Science®Google Scholar Ernsting MJ, Labow RS, Santerre JP. Surface modification of a polycarbonate-urethane using a vitamin-E-derivatized fluoroalkyl surface modifier. Journal of Biomaterials Science, Polymer Edition 2003, 14, 1411–1426. 10.1163/156856203322599743 CASPubMedWeb of Science®Google Scholar Jahangir AR, McClung WG, Cornelius RM, McCloskey CB, Brash JL, Santerre JP. Fluorinated surface-modifying macromolecules: modulating adhesive protein and platelet interactions on a polyether-urethane. Journal of Biomedical Materials Research 2002, 60, 135–147. 10.1002/jbm.10033 CASPubMedWeb of Science®Google Scholar Sanders JE, Lamont SE, Karchin A, Golledge SL, Ratner BD. Fibro-porous meshes made from polyurethane micro-fibers: effects of surface charge on tissue response. Biomaterials 2005, 26, 813–818. 10.1016/j.biomaterials.2004.03.030 CASPubMedWeb of Science®Google Scholar Koike M, Lockwood PE, Wataha JC, Okabe T. Initial cytotoxicity of novel titanium alloys. Journal of Biomedical Materials Research B 2007, 83, 327–331. 10.1002/jbm.b.30799 CASPubMedWeb of Science®Google Scholar Oh K-T, Kang D-K, Choi G-S, Kim K-N. Cytocompatibility and electrochemical properties of Ti–Au alloys for biomedical applications. Journal of Biomedical Materials Research B 2007, 83, 320–326. 10.1002/jbm.b.30798 CASPubMedWeb of Science®Google Scholar Assis SL, Rogero SO, Antunes RA, Padilha AF, Costa I. A comparative study of the in vitro corrosion behavior and cytotoxicity of a superferritic stainless steel, a Ti-13Nb-13Zr alloy, and an austenitic stainless steel in Hank's solution. Journal of Biomedical Materials Research B 2005, 73, 109–116. 10.1002/jbm.b.30205 CASPubMedWeb of Science®Google Scholar Dinnes DL, Marcal H, Mahler SM, Santerre JP, Labow RS. Material surfaces affect the protein expression patterns of human macrophages: a proteomics approach. Journal of Biomedical Materials Research A 2007, 80, 895–908. 10.1002/jbm.a.30967 CASPubMedWeb of Science®Google Scholar Jasty MC, Bragdon C, Burke D, O'Connor D, Lowenstein J, Harris WH. In vivo skeletal responses to porous-surfaced implants subjected to small induced motions. Journal of Bone and Joint Surgery 1997, 79, 707–714. 10.2106/00004623-199705000-00010 CASPubMedWeb of Science®Google Scholar Ward WK, Troupe JE. Assessment of chronically implanted subcutaneous glucose sensors in dogs: the effect of surrounding fluid masses. American Society for Artificial Internal Organs 1999, 45, 555–561. 10.1097/00002480-199911000-00009 CASWeb of Science®Google Scholar Shen M, Pan YV, Wagner MS, Hauch KD, Castner DG, Ratner BD, Horbett TA. Inhibition of monocyte adhesion and fibrinogen adsorption on glow discharge plasma deposited tetraethylene glycol dimethyl ether. Journal of Biomaterials Science, Polymer Edition 2001, 12, 961–978. 10.1163/156856201753252507 CASPubMedWeb of Science®Google Scholar Cao L, Sukavaneshvar S, Ratner BD, Horbett TA. Glow discharge plasma treatment of polyethylene tubing with tetraglyme results in ultralow fibrinogen adsorption and greatly reduced platelet adhesion. Journal of Biomedical Materials Research A 2006, 79, 788–803. 10.1002/jbm.a.30908 CASPubMedWeb of Science®Google Scholar Brodbeck WG, Nakayama Y, Matsuda T, Colton E, Ziats NP, Anderson JM. Biomaterial surface chemistry dictates adherent monocyte/macrophage cytokine expression in vitro . Cytokine 2002, 18, 311–319. 10.1006/cyto.2002.1048 CASPubMedWeb of Science®Google Scholar Goreish HH, Lewis AL, Rose S, Lloyd AW. The effect of phosphorylcholine-coated materials on the inflammatory response and fibrous capsule formation: in vitro and in vivo observations. Journal of Biomedical Materials Research A 2004, 68, 1–9. 10.1002/jbm.a.10141 CASPubMedWeb of Science®Google Scholar Kim K, Kim C, Byun Y. Biostability and biocompatibility of a surface-grafted phospholipid monolayer on a solid substrate. Biomaterials 2004, 25, 33–41. 10.1016/S0142-9612(03)00469-1 CASPubMedWeb of Science®Google Scholar Moro T, Takatori Y, Ishihara K, Konno T, Takigawa Y, Matsushita T, Chung U-I, Nakamura K, Kawaguchi H. Surface grafting of artificial joints with a biocompatible polymer for preventing periprosthetic osteolysis. Nature Materials 2004, 3, 829–836. 10.1038/nmat1233 CASPubMedWeb of Science®Google Scholar Moro T, Takatori Y, Ishihara K, Nakamura K, Kawaguchi H. Frank Stinchfield Award: grafting of biocompatible polymer for longevity of artificial hip joints. Clinical Orthopaedics and Related Research 2006, 453, 58–63. 10.1097/01.blo.0000246553.33434.5f PubMedWeb of Science®Google Scholar Iwasaki Y, Ishihara K. Phosphorylcholine-containing polymers for biomedical applications. Analytical and Bioanalytical Chemistry 2005, 381, 534–546. 10.1007/s00216-004-2805-9 CASPubMedWeb of Science®Google Scholar Geelhood SJ, Horbett TA, Ward WK, Wood MD, Quinn MJ. Passivating protein coatings for implantable glucose sensors: evaluation of protein retention. Journal of Biomedical Research Part B 2006, 81, 251–260. Google Scholar Ulloa L, Doody J, Massague J. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. Nature 1999, 397, 710–713. 10.1038/17826 CASPubMedWeb of Science®Google Scholar Nagata K. Expression and function of heat shock protein 47: a collagen-specific molecular chaperone in the endoplasmic reticulum. Matrix Biology 1998, 16, 379–386. 10.1016/S0945-053X(98)90011-7 CASPubMedWeb of Science®Google Scholar Chen JJ, Zhao S, Cen Y, Liu X-X, Yu R, Wu D-M. Effect of heat shock protein 47 on collagen accumulation in keloid fibroblast cells. British Journal of Dermatology 2007, 156, 1188–1195. 10.1111/j.1365-2133.2007.07898.x CASPubMedWeb of Science®Google Scholar Yamada H, Tajima S, Nishikawa T, Murad S, Pinnell SR. Tranilast, a selective inhibitor of collagen synthesis in human skin fibroblasts. Journal of Biochemistry 1994, 116, 892–897. 10.1093/oxfordjournals.jbchem.a124612 CASPubMedWeb of Science®Google Scholar Kim I, Mogford JE, Witschi C, Nafissi M, Mustoe TA. Inhibition of prolyl 4-hydroxylase reduces scar hypertrophy in a rabbit model of cutaneous scarring. Wound Repair and Regeneration 2003, 11, 368–372. 10.1046/j.1524-475X.2003.11509.x CASPubMedWeb of Science®Google Scholar Saika S, Ooshima A, Hashizume N, Yamanaka O, Tanaka S, Okada Y, Kobata S. Effect of lysyl hydroxylase inhibitor, minoxidil, on ultrastructure and behavior of cultured rabbit subconjunctival fibroblasts. Graefe's Archive for Clinical Experimental Ophthalmology 1995, 233, 347–353. 10.1007/BF00200483 CASPubMedWeb of Science®Google Scholar Czuwara-Ladykowska J, Makiela B, Smith EA, Trojanowska M, Rudnicka L. The inhibitory effects of camptothecin, a topoisomerase I inhibitor, on collagen synthesis in fibroblasts from patients with systemic sclerosis. Arthritis Research 2001, 3, 311–318. 10.1186/ar321 CASPubMedWeb of Science®Google Scholar Kahari VM, Saarialho-Kere U. Matrix metalloproteinases in skin. Experimental Dermatology 1997, 6, 199–213. 10.1111/j.1600-0625.1997.tb00164.x CASPubMedWeb of Science®Google Scholar Pins GD, Collins-Pavao ME, Van De Water L, Yarmush ML, Morgan JR. Plasmin triggers rapid contraction and degradation of fibroblast-populated collagen lattices. Journal of Investigative Dermatology 2000, 114, 647–653. 10.1046/j.1523-1747.2000.00858.x CASPubMedWeb of Science®Google Scholar Ulrich D, Hrynyschyn K, Pallua N. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease. Plastic and Reconstructive Surgery 2003, 112, 1279–1286. 10.1097/01.PRS.0000081462.40448.49 PubMedWeb of Science®Google Scholar Fellenius E, Berglindh T, Sachs G, Olbe L, Elander B, Sjostrand SE, Wallmark B. Substituted benzimidazoles inhibit gastric acid secretion by blocking (H + + K+) ATPase. Nature 1981, 290, 159–161. 10.1038/290159a0 CASPubMedWeb of Science®Google Scholar Spector R, Vesell ES. The power of pharmacological sciences: the example of proton pump inhibitors. Pharmacology 2006, 76, 148–155; discussion 156. 10.1159/000091259 CASPubMedWeb of Science®Google Scholar Hickey T, Kreutzer D, Burgess DJ, Moussy F. Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices. Biomaterials 2002, 23, 1649–1656. 10.1016/S0142-9612(01)00291-5 CASPubMedWeb of Science®Google Scholar Hickey T, Kreutzer D, Burgess DJ, Moussy F. In vivo evaluation of a dexamethasone/ PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices. Journal of Biomedical Materials Research 2002, 61, 180–187. 10.1002/jbm.10016 CASPubMedWeb of Science®Google Scholar Anzano MA, Roberts AB, Meyers CA, Komoriya A, Lamb LC, Smith JM, Sporn MB. Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells. Cancer Research 1982, 42, 4776–4778. CASPubMedWeb of Science®Google Scholar Katou F, Ohtani H, Nagura H, Motegi K. Procollagen-positive fibroblasts predominantly express fibrogenic growth factors and their receptors in human encapsulation process against foreign body. Journal of Pathology 1998, 186, 201–208. 10.1002/(SICI)1096-9896(1998100)186:2<201::AID-PATH157>3.0.CO;2-C CASPubMedWeb of Science®Google Scholar Hernandez-Pando R, Bornstein QL, Leon DA, Orozco EH, Madrigal VK, Cordero EM. Inflammatory cytokine production by immunological and foreign body multinucleated giant cells. Immunology 2000, 100, 352–358. 10.1046/j.1365-2567.2000.00025.x CASPubMedWeb of Science®Google Scholar Shah M, Foreman DM, Ferguson MW. Neutralisation of TGF-b1 and TGF-b2or exogenous addition of TGF-b3 to cutaneous rat wounds reduces scarring. Journal of Cell Science 1995, 108, 985–1002. CASPubMedWeb of Science®Google Scholar Okadome T, Oeda E, Saitoh M, Ichijo H, Moses HL, Miyazono K, Kawabata M. Characterization of the interaction of FKBP12 with the transforming growth factor-b type I receptor in vivo . Journal of Biological Chemistry 1996, 271, 21687–21690. 10.1074/jbc.271.36.21687 CASPubMedWeb of Science®Google Scholar Young GD, Murphy-Ullrich JE. Molecular interactions that confer latency to transforming growth factor-beta. Journal of Biological Chemistry 2004, 279, 38032–38039. 10.1074/jbc.M405658200 CASPubMedWeb of Science®Google Scholar Ribeiro SM, Poczatek M, Schultz-Cherry S, Villain M, Murphy-Ullrich JE. The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-b. Journal of Biological Chemistry 1999, 274, 13586–13593. 10.1074/jbc.274.19.13586 CASPubMedWeb of Science®Google Scholar Gharaee-Kermani M, Denholm EM, Phan SH. Costimulation of fibroblast collagen and transforming growth factor beta1 gene expression by monocyte chemoattractant protein-1 via specific receptors. Journal of Biological Chemistry 1996, 271, 17779–17784. 10.1074/jbc.271.30.17779 CASPubMedWeb of Science®Google Scholar Duncan MR, Frazier KS, Abramson S, Williams S, Klapper H, Huang X, Grotendorst GR. Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP. Journal of the Federation of American Societies for Experimental Biology 1999, 13, 1774–1486. 10.1096/fasebj.13.13.1774 CASPubMedWeb of Science®Google Scholar Chen Y, Blom IE, Sa S, Goldschmeding R, Abraham DJ, Leask A. CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC. Kidney International 2002, 62, 1149–1159. 10.1111/j.1523-1755.2002.kid567.x CASPubMedWeb of Science®Google Scholar Gretzer C, Emanuelsson L, Liljensten E, Thomsen P. The inflammatory cell influx and cytokines changes during transition from acute inflammation to fibrous repair around implanted materials. Journal of Biomaterials Science, Polymer Edition 2006, 17, 669–687. 10.1163/156856206777346340 CASPubMedWeb of Science®Google Scholar Unemori EN, Beck LS, Lee WP, Xu Y, Siegel M, Keller G, Liggitt HD, Bauer EA, Amento EP. Human relaxin decreases collagen accumulation in vivo in two rodent models of fibrosis. Journal of Investigative Dermatology 1993, 101, 280–285. 10.1111/1523-1747.ep12365206 CASPubMedWeb of Science®Google Scholar Williams EJ, Benyon RC, Trim N, Hadwin R, Grove BH, Arthur MJP, Unemori EN, Iredale JP. Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo . Gut 2001, 49, 577–583. 10.1136/gut.49.4.577 CASPubMedWeb of Science®Google Scholar Granstein RD, Flotte TJ, Amento EP. Interferons and collagen production. Journal of Investigative Dermatology 1990, 95, 75S–80S. 10.1111/1523-1747.ep12874789 CASPubMedWeb of Science®Google Scholar Fais S, Burgio VL, Silvestri M, Capobianchi MR, Pacchiarotti A, Pallone F. Multinucleated giant cells generation induced by interferon-gamma. Changes in the expression and distribution of the intercellular adhesion molecule-1 during macrophages fusion and multinucleated giant cell formation. Laboratory Investigation 1994, 71, 737–744. CASPubMedWeb of Science®Google Scholar Khouw IM, van Wachem PB, De Leij LFMH, Van Luyn MJA. Inhibition of the tissue reaction to a biodegradable biomaterial by monoclonal antibodies to IFN-gamma. Journal of Biomedical Materials Research 1998, 41, 202–210. 10.1002/(SICI)1097-4636(199808)41:2<202::AID-JBM4>3.0.CO;2-M CASPubMedWeb of Science®Google Scholar Miles RH, Paxton TP, Zacheis D, Dries DJ, Gamelli RL. Systemic administration of interferon-gamma impairs wound healing. Journal of Surgical Research 1994, 56, 288–294. 10.1006/jsre.1994.1045 CASPubMedWeb of Science®Google Scholar Strutz F, Heeg M, Kochsiek T, Siemers G, Zeisberg M, Muller GA. Effects of pentoxifylline, pentifylline and gamma-interferon on proliferation, differentiation, and matrix synthesis of human renal fibroblasts. Nephrology Dialysis Transplantation 2000, 15, 1535–1546. 10.1093/ndt/15.10.1535 CASPubMedWeb of Science®Google Scholar Higashi K, Inagaki Y, Fujimori K, Nakao A, Kaneko H, Nakatsuka I. Interferon-gamma interferes with transforming growth factor-beta signaling through direct interaction of YB-1 with Smad3. Journal of Biological Chemistry 2003, 278, 43470–43479. 10.1074/jbc.M302339200 CASPubMedWeb of Science®Google Scholar Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. New England Journal of Medicine 1993, 329, 1456–1162. 10.1056/NEJM199311113292004 CASPubMedWeb of Science®Google Scholar Perico N, Ruggenenti P, Remuzzi G. Losartan in diabetic nephropathy. Expert Review of Cardiovascular Therapy 2004, 2, 473–483. CASPubMedGoogle Scholar Sharma K, Eltayeb BO, McGowan TA, Dunn SR, Alzahabi B, Rohde R, Ziyadeh FN, Lewis EJ. Captopril-induced reduction of serum levels of transforming growth factor-beta1 correlates with long-term renoprotection in insulin-dependent diabetic patients. American Journal of Kidney Diseases 1999, 34, 818–823. 10.1016/S0272-6386(99)70037-5 CASPubMedWeb of Science®Google Scholar Abiko M, Rodgers KE, Campeau JD, Nakamura RM, Dizerega GS. Alterations of angiotensin II receptor levels in full-thickness excisional wounds in rat skin. Wound Repair and Regeneration 1996, 4, 363–367. 10.1046/j.1524-475X.1996.40313.x CASPubMedGoogle Scholar Sun Y, Weber KT. Angiotensin-converting enzyme and wound healing in diverse tissues of the rat. Journal of Laboratory and Clinical Medicine 1996, 127, 94–101. 10.1016/S0022-2143(96)90170-5 CASPubMedWeb of Science®Google Scholar Gilligan BJ, Shults MC, Rhodes RK, Updike SJ. Evaluation of a subcutaneous glucose sensor out to 3 months in a dog model. Diabetes Care 1994, 17, 882–887. 10.2337/diacare.17.8.882 CASPubMedWeb of Science®Google Scholar Klueh U, Dorsky DI, Kreutzer DL. Use of vascular endothelial cell growth factor gene transfer to enhance implantable sensor function in vivo . Journal of Biomedical Materials Research A 2003, 67, 1072–1086. 10.1002/jbm.a.20041 PubMedWeb of Science®Google Scholar Klueh U, Dorsky DI, Kreutzer DL. Enhancement of implantable glucose sensor function in vivo using gene transfer-induced neovascularization. Biomaterials 2005, 26, 1155–1163. 10.1016/j.biomaterials.2004.04.017 CASPubMedWeb of Science®Google Scholar Spaide RF, Fisher YL. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina 2006, 26, 275–278. 10.1097/00006982-200603000-00004 PubMedWeb of Science®Google Scholar Citing Literature In Vivo Glucose Sensing, Volume 174 ReferencesRelatedInformation
Publication Year: 2009
Publication Date: 2009-11-23
Language: en
Type: other
Indexed In: ['crossref']
Access and Citation
Cited By Count: 2
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot